ReviewThe clinical respiratory journal2022
Challenges of vaccination and herd immunity in COVID-19 and management strategies.
Review in The clinical respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 28 citations in OpenAlex.
- Artificial intelligence in drug resistance management.3 Biotech · 2025Review
- COVID-19 vaccine hesitancy and its predictors among healthcare workers in a tertiary hospital in Ghana: A cross-sectional survey.PloS one · 2025Article
- Real-world COVID-19 vaccine effectiveness in Zimbabwe: A test-negative case-control study.Journal of public health in Africa · 2025Article
- Observational
- COVID-19 vaccination patterns among oral cancer patients: A comprehensive analysis in a medical center in Taiwan.Journal of dental sciences · 2025Article
- Anti-COVID-19 Vaccination in the Italian General Population: Proactive Clinical Risk Analysis Using Failure Mode, Effects, and Criticality Analysis Technique.Healthcare (Basel, Switzerland) · 2024Article
- Vaccine Hesitancy and Associated Factors Amongst Health Professionals: A Scoping Review of the Published Literature.Vaccines · 2024Article
- COVID-19 vaccine hesitancy in Ethiopia: a latent class analysis.BMC public health · 2024Article
- Design of multi-epitope chimeric vaccine against Monkeypox virus and SARS-CoV-2: A vaccinomics perspective.Journal of cellular and molecular medicine · 2024Article
- Cognizance and mitigation of falsified immunization documentation: Analyzing the consequences for public health in Nigeria, with a focus on counterfeited COVID-19 vaccination cards: A case report.Health science reports · 2024Article
- Factors Associated to Community Practices Toward the COVID-19 Pandemic: A Cross-Sectional Study in Indonesia.Journal of multidisciplinary healthcare · 2024Article
- Mapping vulnerability for increased COVID-19 susceptibility and worse outcomes: a scoping review.Frontiers in public health · 2024Article
- The impact of health beliefs and trust in health information sources on SARS-CoV-2 vaccine uptake.Frontiers in public health · 2024Article
- Article
- Factors affecting the community's attitude toward COVID-19 vaccination: cross-sectional study.Revista brasileira de enfermagem · 2023Article
- Interferons in COVID-19: missed opportunities to prove efficacy in clinical phase III trials?Frontiers in medicine · 2023Article
- Challenges of vaccination and herd immunity in COVID-19 and management strategies.The clinical respiratory journal · 2022Review
- Predictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study.Frontiers in public health · 2022Article
- Perception and practices on COVID-19 vaccination and booster dose acceptability among health-care workers - A questionnaire-based study.Perspectives in clinical researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
Coronavirus disease 2019 (COVID-19), the highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide with millions of cases and more than 5 million deaths to date. SARS-CoV-2 has caused serious damage all over the world with many countries experiencing the third or the fourth wave of the viral disease outbreaks, mainly due to the emergence of mutant variants. Those who unvaccinated remain most vulnerable to COVID-19 and its variants. COVID-19 vaccination, along with prevention strategies, is a critical measure to defense against the disease. COVID-19 vaccination can reduce the spread of virus and help protect susceptible population. Although herd immunity might not be realized solely by vaccination, COVID-19 vaccines have been proved to be effective in reducing the risk of severe disease, hospitalization, and even death. It is recommended that people get vaccinated as soon as they are eligible. This review summarizes the recent SARS-CoV-2 variants that brought challenges for vaccination and herd immunity and discusses promising management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.